Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Janette Sutton"'
Autor:
Magdalena Dorywalska, Pavel Strop, Jody A Melton-Witt, Adela Hasa-Moreno, Santiago E Farias, Meritxell Galindo Casas, Kathy Delaria, Victor Lui, Kris Poulsen, Janette Sutton, Gary Bolton, Dahui Zhou, Ludivine Moine, Russell Dushin, Thomas-Toan Tran, Shu-Hui Liu, Mathias Rickert, Davide Foletti, David L Shelton, Jaume Pons, Arvind Rajpal
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0132282 (2015)
The efficacy of an antibody-drug conjugate (ADC) is dependent on the properties of its linker-payload which must remain stable while in systemic circulation but undergo efficient processing upon internalization into target cells. Here, we examine the
Externí odkaz:
https://doaj.org/article/523b58d2569a488d9bf12b8cb87145b2
Autor:
Yi Zhang, Silvia K. Tacheva-Grigorova, Janette Sutton, Zea Melton, Yvonne S.L. Mak, Cecilia Lay, Bryan A. Smith, Tao Sai, Thomas Van Blarcom, Barbra J. Sasu, Siler H. Panowski
Publikováno v:
Clinical Cancer Research. 29:971-985
Purpose:Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options. Delta-like ligand 3 (DLL3) is highly expressed on SCLC and several other types of neuroendocrine cancers, with limited normal tissue RNA expression in brai
Autor:
Javier Chaparro-Riggers, Barbra J. Sasu, Siler H. Panowski, Thomas J. Van Blarcom, Bijan Boldajipour, Yi Zhang, Zea Melton, Cecilia Lay, Janette Sutton, Spencer Park, Andrew R. Nager, Regina J. Lin
Supplementary Data from Design and Validation of Inducible TurboCARs with Tunable Induction and Combinatorial Cytokine Signaling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06f1884a4084a106e78725cbd7dac8cc
https://doi.org/10.1158/2326-6066.22545443
https://doi.org/10.1158/2326-6066.22545443
Autor:
Javier Chaparro-Riggers, Barbra J. Sasu, Siler H. Panowski, Thomas J. Van Blarcom, Bijan Boldajipour, Yi Zhang, Zea Melton, Cecilia Lay, Janette Sutton, Spencer Park, Andrew R. Nager, Regina J. Lin
Although cytokine support can enhance CAR T-cell function, coadministering cytokines or engineering CAR T cells to secrete cytokines can result in toxicities. To mitigate these safety risks, we engineered iTurboCAR T cells that coexpress a novel indu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1d748d06d80b487e1308b2a261e5e9f
https://doi.org/10.1158/2326-6066.c.6550943.v1
https://doi.org/10.1158/2326-6066.c.6550943.v1
Autor:
Siler H. Panowski, Barbra J. Sasu, Thomas Van Blarcom, Tao Sai, Bryan A. Smith, Cecilia Lay, Yvonne S.L. Mak, Zea Melton, Janette Sutton, Silvia K. Tacheva-Grigorova, Yi Zhang
Fig. S6. Infusion of DLL3 CAR T cells did not induce toxicity in non-tumor-bearing model or subcutaneous tumor model.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3110757de6853463ce246bf92d802c24
https://doi.org/10.1158/1078-0432.22490318
https://doi.org/10.1158/1078-0432.22490318
Autor:
Siler H. Panowski, Barbra J. Sasu, Thomas Van Blarcom, Tao Sai, Bryan A. Smith, Cecilia Lay, Yvonne S.L. Mak, Zea Melton, Janette Sutton, Silvia K. Tacheva-Grigorova, Yi Zhang
Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82447ccd8ad8892e0f7a539dd1808e1
https://doi.org/10.1158/1078-0432.22490312.v1
https://doi.org/10.1158/1078-0432.22490312.v1
Autor:
Siler H. Panowski, Barbra J. Sasu, Thomas Van Blarcom, Tao Sai, Bryan A. Smith, Cecilia Lay, Yvonne S.L. Mak, Zea Melton, Janette Sutton, Silvia K. Tacheva-Grigorova, Yi Zhang
Purpose:Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options. Delta-like ligand 3 (DLL3) is highly expressed on SCLC and several other types of neuroendocrine cancers, with limited normal tissue RNA expression in brai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a67a25302384968a4cfa6871e75b7fc2
https://doi.org/10.1158/1078-0432.c.6533129
https://doi.org/10.1158/1078-0432.c.6533129
Autor:
Janette Sutton, Cesar Sommer, Hsin-Yuan Cheng, Moustafa Hamze, Javier Chaparro-Riggers, Julianne Smith, Danielle Dettling, Duy Nguyen, Barbra Sasu, Julien Valton, Ivana Djuretic, Yik Andy Yeung
Publikováno v:
Mol Ther
Patients with relapsed or refractory acute myeloid leukemia (AML) have a dismal prognosis and limited treatment options. Chimeric antigen receptor (CAR) T cells have achieved unprecedented clinical responses in patients with B cell leukemias and lymp
Autor:
Regina J. Lin, Andrew R. Nager, Spencer Park, Janette Sutton, Cecilia Lay, Zea Melton, Yi Zhang, Bijan Boldajipour, Thomas J. Van Blarcom, Siler H. Panowski, Barbra J. Sasu, Javier Chaparro-Riggers
Publikováno v:
Cancer immunology research. 10(9)
Although cytokine support can enhance CAR T-cell function, coadministering cytokines or engineering CAR T cells to secrete cytokines can result in toxicities. To mitigate these safety risks, we engineered iTurboCAR T cells that coexpress a novel indu
Autor:
Lang Shanshan, Siler Panowski, Regina Lin, Barbra Sasu, Cecilia Lay, Surabhi Srinivasan, Yi Zhang, Tom Van Blarcom, Janette Sutton, Candice Manion
Publikováno v:
Cancer Research. 81:1519-1519
CAR T cell therapy has attained unprecedented success in the treatment of hematological malignancies. However, clinical benefit in solid tumor indications has been limited, potentially in part due to suppressive solid tumor microenvironments (TME) th